A

AsclepiX Therapeutics, Inc.

13 employees

AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
oncology
peptides
Therapeutics
biotechnology
age-related macular degeneration
ophthalmology
macular edema
Health Diagnostics
therapeutics
Health Care

Date founded

2011

Funding rounds raised

Total raised

$35M

from 4 investors over 4 rounds

A

AsclepiX Therapeutics, Inc. raised $35M on June 24, 2020

Investors: Rapha Capital Management, LLC and Perceptive Advisors

A

AsclepiX Therapeutics, Inc. raised $5M on November 13, 2018

Investors: Rapha Capital Management, LLC and Salem Partners LLC

FAQ